Locations
North America · Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series C+
founded in
2018
Dewpoint Therapeutics is a pioneering biotechnology company focused on drug discovery through the modulation of biomolecular condensates. By integrating advanced AI technologies with state-of-the-art experimental methods, Dewpoint aims to develop innovative therapies for complex diseases, including cancer and neurodegenerative disorders. The company has established a robust pipeline of therapeutic programs and partnerships with leading pharmaceutical firms, positioning itself as a leader in the condensate biotechnology space. With significant funding raised and a strong team of experts, Dewpoint is well-equipped to advance its groundbreaking research and deliver transformative medicines to patients.
Something looks off?